Table 3 Clinical characteristics of the main non-AIDS defining cancer (NADC) identified

Age (years)^b

39.9 ± 9.1

42.2 ± 7.8

33.4 ± 5.5

49.1 ± 8.1

47 and 51

57.3 ± 11.3

43.2 ± 1.9

50.3 ± 10.8

CD4 (cells/µL)^c

162 (106, 302)

270 (152, 457)

117 (33, 421)

214 (103, 513)

219 and 231

369 (249, 593)

890 (472, 927)

481 (371, 805)

Viral load (copies/mL)^c

< 40 (< 40, 2168)

< 40 (< 40, 78,000)

51,930 (51, 750,000)

17,970 (2475, 34,205)

< 40 and 21,300

< 40 (< 40, 16,300)

< 40 (< 40, 50)

< 40 (< 40, 55)

Follow-up (weeks)^cd

8.9 (2.7, 31)

13.9 (5.8, 30.2)

13.6 (4.3, 29.1)

10.7 (8.5, 22.8)

1.7 and 5.9

22.1 (6.5, 49.6)

9.7 (7.4, 26.8)

9.2 (3.2, 26.9)

Alive

30 (83.3)

9 (56.2)

0

8 (88.9)

1 (50)

6 (85.7)

6 (85.7)

11 (84.6)

Dead

6 (16.7)

7 (43.8)

13 (100)

1 (50)

1 (50)

1 (43.3)

1 (43.3)

2 (15.4)